Nutrición y Diabetes
NUTRICIÓN Y DIABETES
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (103)
2024
-
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
United European Gastroenterology Journal
-
Hydroxycitrate delays early mortality in mice and promotes muscle regeneration while inducing a rich hepatic energetic status
Aging Cell
-
Novel insights into metabolic-associated steatotic liver disease preclinical models
Liver International, Vol. 44, Núm. 3, pp. 644-662
-
Persimmon Fiber-Rich Ingredients Promote Anti-Inflammatory Responses and the Growth of Beneficial Anti-Inflammatory Firmicutes Species from the Human Colon
Nutrients, Vol. 16, Núm. 15
2023
-
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
International Journal of Molecular Sciences, Vol. 24, Núm. 24
-
Editorial: Look who’s talking: Dialogues with beta cells
Frontiers in Endocrinology
-
Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery
Frontiers in Immunology, Vol. 14
-
Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging
Communications Biology, Vol. 6, Núm. 1
-
Nutrition could prevent or promote non-alcoholic fatty liver disease: an opportunity for intervention
BMJ
-
Preconception exposure to malathion and glucose homeostasis in rats: Effects on dams during pregnancy and post-term periods, and on their progeny.
Environmental Pollution, Vol. 316
-
Rationale for combined therapies in severe-to-critical COVID-19 patients
Frontiers in Immunology, Vol. 14
-
Umbilical cord mesenchymal stromal cells transplantation delays the onset of hyperglycemia in the RIP-B7.1 mouse model of experimental autoimmune diabetes through multiple immunosuppressive and anti-inflammatory responses
Frontiers in Cell and Developmental Biology, Vol. 11
-
We are what we eat: The role of lipids in metabolic diseases
Advances in Food and Nutrition Research (Academic Press Inc.), pp. 173-219
2022
-
Considerations for Clinical Use of Mesenchymal Stromal Cells
Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 51-102
-
Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver
Frontiers in Endocrinology, Vol. 13
-
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective
Seminars in Liver Disease, Vol. 42, Núm. 4, pp. 434-445
-
Human Omental Mesothelial Cells Impart an Immunomodulatory Landscape Impeding B-and T-Cell Activation
International Journal of Molecular Sciences, Vol. 23, Núm. 11
-
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
Scientific Reports, Vol. 12, Núm. 1
-
Mesenchymal Stromal Cells for COVID-19 Critical Care Patients: A Present Hope
Handbook of Stem Cell Therapy: Volume 1 (Springer Nature), pp. 163-191
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734